Association of Genetic Variants Influencing Lipid Levels with Coronary Artery Disease in Japanese Individuals

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Takeuchi, Fumihiko ^a   Isono, Masato ^a   Katsuya, Tomohiro ^b   Yokota, Mitsuhiro ^c   Yamamoto, Ken ^d   Nabika, Toru ^e   Shimokawa, Kazuro ^a   Nakashima, Eitaro ^f,g   Sugiyama, Takao ^h   Rakugi, Hiromi ^b   Yamaguchi, Shuhei ^e   Ogihara, Toshio ^b,i   Yamori, Yukio ^j   Kato, Norihiro ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^f NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g CHUBU ROSAI HOSPITAL   (Japan)

^h INSTITUTE FOR ADULT DISEASES   (Japan)

ⁱ MORINOMIYA UNIVERSITY OF MEDICAL SCIENCES   (Japan)

^j MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A5; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; SORTILIN; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; APOA5 GENE; APOB GENE; APOE C1 GENE; APOE GENE; ARTICLE; CASE CONTROL STUDY; CETP GENE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; JAPANESE; LDLR GENE; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SORT1 GENE;

APOLIPOPROTEINS A; APOLIPOPROTEINS B; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84866866856     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046385     Document Type: Article

References (41)

1. Namboodiri KK, Kaplan EB, Heuch I, Elston RC, Green PP, et al. (1985) The Collaborative Lipid Research Clinics Family Study: biological and cultural determinants of familial resemblance for plasma lipids and lipoproteins. Genet Epidemiol 2: 227-254.
2. Khera AV, Rader DJ, (2009) Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics. Trends Cardiovasc Med 19: 195-201.
3. Soutar AK, (2010) Rare genetic causes of autosomal dominant or recessive hypercholesterolaemia. IUBMB Life 62: 125-131.
4. Willer CJ, Mohlke KL, (2012) Finding genes and variants for lipid levels after genome-wide association analysis. Curr Opin Lipidol 23: 98-103.
5. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707-713.
6. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, et al. (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40: 161-169.
7. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, et al. (2008) Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40: 189-197.
8. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, et al. (2009) Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 41: 47-55.
9. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, et al. (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41: 56-65.
10. Sabatti C, Service SK, Hartikainen AL, Pouta A, Ripatti S, et al. (2009) Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 41: 35-46.
11. Sandhu MS, Waterworth DM, Debenham SL, Wheeler E, Papadakis K, et al. (2008) LDL-cholesterol concentrations: a genome-wide association study. Lancet 371: 483-491.
12. Chasman DI, Paré G, Zee RY, Parker AN, Cook NR, et al. (2008) Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ Cardiovasc Genet 1: 21-30.
13. Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, et al. (2008) Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 82: 139-149.
14. Chasman DI, Paré G, Mora S, Hopewell JC, Peloso G, et al. (2009) Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet 5: e1000730.
15. Heid IM, Boes E, Müller M, Kollerits B, Lamina C, et al. (2008) Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions. Circ Cardiovasc Genet 1: 10-20.
16. Talmud PJ, Drenos F, Shah S, Shah T, Palmen J, et al. (2009) Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet 85: 628-642.
17. Dumitrescu L, Carty CL, Taylor K, Schumacher FR, Hindorff LA, et al. (2011) Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study. PLoS Genet 7: e1002138.
18. Chang MH, Ned RM, Hong Y, Yesupriya A, Yang Q, et al. (2011) Racial/ethnic variation in the association of lipid-related genetic variants with blood lipids in the US adult population. Circ Cardiovasc Genet 4: 523-533.
19. Kim YJ, Go MJ, Hu C, Hong CB, Kim YK, et al. (2011) Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits. Nat Genet 43: 990-995.
20. Ordovás JM, Robertson R, Cléirigh EN, (2011) Gene-gene and gene-environment interactions defining lipid-related traits. Curr Opin Lipidol 22: 129-136.
21. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd, (1961) Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med 55: 33-50.
22. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, et al. (2005) Cholesterol Treatment Trialists' (CTT) Collaborators (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366: 1267-1278.
23. Kathiresan S, Melander O, Anevski D, Guiducci C, Burtt NP, et al. (2008) Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 358: 1240-1249.
24. Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, et al. (2010) Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 30: 2264-2276.
25. Drenos F, Talmud PJ, Casas JP, Smeeth L, Palmen J, et al. (2009) Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk. Hum Mol Genet 18: 2305-2316.
26. Tsuchihashi-Makaya M, Serizawa M, Yanai K, Katsuya T, Takeuchi F, et al. (2009) Gene-environmental interaction regarding alcohol-metabolizing enzymes in the Japanese general population. Hypertens Res 32: 207-213.
27. Takeuchi F, Yokota M, Yamamoto K, Nakashima E, Katsuya T, et al. (2012) Genome-wide association study of coronary artery disease in the Japanese. Eur J Hum Genet 20: 333-340.
28. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration (2010) Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, et al. (2010) Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 375: 1634-1639.
29. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43: 333-338.
30. Erdmann J, Grosshennig A, Braund PS, König IR, Hengstenberg C, et al. (2009) New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 41: 280-282.
31. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
32. Takeuchi F, Serizawa M, Yamamoto K, Fujisawa T, Nakashima E, et al. (2009) Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 58: 1690-1699.
33. Cochran WG, (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
34. Anand SS, Xie C, Paré G, Montpetit A, Rangarajan S, et al. (2009) Genetic variants associated with myocardial infarction risk factors in over 8000 individuals from five ethnic groups: The INTERHEART Genetics Study. Circ Cardiovasc Genet 2: 16-25.
35. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, et al. (2007) Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298: 1300-1311.
36. Boes E, Coassin S, Kollerits B, Heid IM, Kronenberg F, (2009) Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Exp Gerontol 44: 136-160.
37. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, et al. (1996) Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 97: 2917-2923.
38. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB, (2010) Rare variants create synthetic genome-wide associations. PLoS Biol 8: e1000294.
39. Takeuchi F, Kobayashi S, Ogihara T, Fujioka A, Kato N, (2011) Detection of common single nucleotide polymorphisms synthesizing quantitative trait association of rarer causal variants. Genome Res 21: 1122-1130.
40. Zhou L, Ding H, Zhang X, He M, Huang S, et al. (2011) Genetic variants at newly identified lipid loci are associated with coronary heart disease in a Chinese Han population. PLoS One 6: e27481.
41. Benn M, (2009) Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review. Atherosclerosis 206: 17-30.